- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06401057
Register for Longitudinal Recording of Brain Function
May 1, 2024 updated by: Schwendner Maximilian, University Hospital Heidelberg
Register for Longitudinal Recording of Brain Function in Patients With Brain Diseases
The aim of this observational register study is to establish a registry that completely records and compiles the data from routinely performed technical examinations (navigated transcranial magnetic stimulation, intraoperative neuromonitoring and stimulation, MRI imaging including tractography and connectome) and clinical tests over time (pre-, intra- and postoperative, under adjuvant therapy, as part of follow-up care) of patients with intracranial masses and lesions.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Heidelberg, Germany, 69120
- Recruiting
- Department of Neurosurgery Heidelberg University Hospital
-
Contact:
- Maximilan Schwendner, MD
- Phone Number: +49 6221 56 6999
- Email: maximilian.schwendner@med.uni-heidelberg.de
-
Contact:
- Sebastian Ille, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with brain masses/lesions (especially tumors (cerebral and non-cerebral, inflammation (infectious and non-infectious), vascular pathologies)
Description
Inclusion Criteria:
- Intracranial lesion
- Age ≥ 18 years
- Written consent to participate in the study
Exclusion Criteria:
- Age < 18 years
- Patients not able to give consent
- Patients with intracranial ferromagnetic metal implants
- Patients with implanted electronic devices
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive status
Time Frame: until last patient FU up to 48 months
|
Higher cognitive functions - determined by the Montreal Cognitive Assessment (MocA)
|
until last patient FU up to 48 months
|
|
Language status
Time Frame: until last patient FU up to 48 months
|
Language function tested by the Aphasia Check List
|
until last patient FU up to 48 months
|
|
Motor status
Time Frame: until last patient FU up to 48 months
|
Motor function according to the BMRC scale
|
until last patient FU up to 48 months
|
|
cortical data
Time Frame: until last patient FU up to 48 months
|
cortical nTMS-Data - distribution according the cortical parellation system
|
until last patient FU up to 48 months
|
|
Fiber tracts
Time Frame: until last patient FU up to 48 months
|
Volume of fiber tracts
|
until last patient FU up to 48 months
|
|
Fiber tracts
Time Frame: until last patient FU up to 48 months
|
fractional anisotropy of fiber tracts
|
until last patient FU up to 48 months
|
|
structural imaging (Connectome)
Time Frame: until last patient FU up to 48 months
|
characteristics of Connectome and Disconnectome analysis (Global Efficiency value)
|
until last patient FU up to 48 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
January 1, 2028
Study Registration Dates
First Submitted
January 7, 2024
First Submitted That Met QC Criteria
May 1, 2024
First Posted (Actual)
May 6, 2024
Study Record Updates
Last Update Posted (Actual)
May 6, 2024
Last Update Submitted That Met QC Criteria
May 1, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- Fun-Reg
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
For selected subgroups, data sharing is possible depending on data safety regulations
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients With Brain Masses/Lesions
-
Gustave Roussy, Cancer Campus, Grand ParisNot yet recruitingPatients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Penile Site | Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Anal Site | Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Vulvar Site | Patients... and other conditions
-
JW Medical Systems LtdNot yet recruiting
-
American Society for Gastrointestinal EndoscopyMidwest Biomedical Research FoundationUnknownMediastinal or Intra-abdominal Lymphadenopathy, | Pancreatic Masses, | Left Adrenal Masses, | Gastrointestinal Submucosal Lesions, and | Liver MassesUnited States
-
Misr International UniversityCompletedPatients With Deep Carious LesionsEgypt
-
Damascus UniversityCompletedPatients With Deep Carious LesionsSyrian Arab Republic
-
University Health Network, TorontoThe Kidney Foundation of Canada; Canadian Urologic Oncology GroupCompletedPatients With Newly Diagnosed Small Renal Masses(<4cm)Canada
-
Texas Tech University Health Sciences Center, El...CompletedPancreatic or Peripancreatic Lesions | Lesions in the Esophagus, Stomach, Duodenum or Rectum | Mediastinal ( Chest) Masses | Enlarged Lymph NodesUnited States
-
Misr International UniversityNational Research Centre, EgyptActive, not recruitingPatients With Deep Carious Lesions | Deep Carious Lesion | Deep Caries Lesion of Pemanent TeethEgypt
-
Assiut UniversityUnknownPatients Who Are Diagnosed to Have Intracranial Lesions
-
Chinese University of Hong KongRecruiting